Equities

Linical Co Ltd

2183:TYO

Linical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)346.00
  • Today's Change1.00 / 0.29%
  • Shares traded24.20k
  • 1 Year change-36.63%
  • Beta0.7112
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Linical Co Ltd (2183:TYO) closed at 346.00, 6.46% above its 52-week low of 325.00, set on Aug 05, 2024.
52-week range
Today
325.00Aug 05 2024557.00Nov 22 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open350.00
High350.00
Low342.00
Bid--
Offer--
Previous close345.00
Average volume43.90k
Shares outstanding24.74m
Free float12.27m
P/E (TTM)--
Market cap8.56bn JPY
EPS (TTM)-5.36
JPY
Annual div (ADY)15.00
JPY
Annual div yield (ADY)4.34%
Div ex-dateMar 28 2024
Div pay-dateJun 12 2024
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
More ▼

Events & Activity

  • 2183:TYO price moved over +1.18% to 343.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.